CN105566406A - Preparation method of fluorodesoxyribofuranose - Google Patents
Preparation method of fluorodesoxyribofuranose Download PDFInfo
- Publication number
- CN105566406A CN105566406A CN201511020367.0A CN201511020367A CN105566406A CN 105566406 A CN105566406 A CN 105566406A CN 201511020367 A CN201511020367 A CN 201511020367A CN 105566406 A CN105566406 A CN 105566406A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- preparation
- drip
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 145
- 150000001875 compounds Chemical class 0.000 claims abstract description 110
- 238000000034 method Methods 0.000 claims abstract description 32
- 238000001953 recrystallisation Methods 0.000 claims abstract description 28
- PIGNSJBCTZRHTO-UHFFFAOYSA-N CC([CH2-])=O.OCC(O)C=O Chemical compound CC([CH2-])=O.OCC(O)C=O PIGNSJBCTZRHTO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000004821 distillation Methods 0.000 claims abstract description 14
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 100
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 96
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 78
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 64
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 64
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 60
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 43
- 229910052757 nitrogen Inorganic materials 0.000 claims description 40
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 36
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 31
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 27
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 25
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims description 24
- OEGAMYZOUWNLEO-UHFFFAOYSA-N [butyl(dimethyl)silyl] trifluoromethanesulfonate Chemical group CCCC[Si](C)(C)OS(=O)(=O)C(F)(F)F OEGAMYZOUWNLEO-UHFFFAOYSA-N 0.000 claims description 21
- 238000003786 synthesis reaction Methods 0.000 claims description 21
- 230000015572 biosynthetic process Effects 0.000 claims description 20
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 18
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 claims description 18
- VGOALPIDEXVYQI-UHFFFAOYSA-N 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-n-[3-imidazol-1-yl-5-(trifluoromethyl)phenyl]-4-methylbenzamide Chemical compound C1=C(C#CC=2N3N=CC=CC3=NC=2)C(C)=CC=C1C(=O)NC(C=C(C=1)C(F)(F)F)=CC=1N1C=CN=C1 VGOALPIDEXVYQI-UHFFFAOYSA-N 0.000 claims description 17
- UNSHMXUHOHBLIQ-UHFFFAOYSA-N 3-[4-chloro-3-(2-methylphenoxy)naphthalen-1-yl]-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione Chemical compound ClC1=C(C=C(C2=CC=CC=C12)N1C(NC(=CC1=O)C(F)(F)F)=O)OC1=C(C=CC=C1)C UNSHMXUHOHBLIQ-UHFFFAOYSA-N 0.000 claims description 16
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical group [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 14
- 229940126639 Compound 33 Drugs 0.000 claims description 13
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 claims description 13
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 claims description 13
- BFYABQYOMQWRSO-UHFFFAOYSA-N 1-bromoethyl 2-fluoroacetate Chemical compound FCC(=O)OC(C)Br BFYABQYOMQWRSO-UHFFFAOYSA-N 0.000 claims description 12
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical group IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 229940043279 diisopropylamine Drugs 0.000 claims description 9
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 claims description 7
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims description 7
- PIGNSJBCTZRHTO-DFWYDOINSA-N CC([CH2-])=O.OC[C@@H](O)C=O Chemical compound CC([CH2-])=O.OC[C@@H](O)C=O PIGNSJBCTZRHTO-DFWYDOINSA-N 0.000 claims description 7
- 229940125877 compound 31 Drugs 0.000 claims description 7
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims description 6
- 229940125878 compound 36 Drugs 0.000 claims description 6
- 238000006482 condensation reaction Methods 0.000 claims description 6
- -1 ethyl ester compound Chemical class 0.000 claims description 6
- 239000012434 nucleophilic reagent Substances 0.000 claims description 6
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 claims description 5
- 238000010306 acid treatment Methods 0.000 claims description 5
- 238000006480 benzoylation reaction Methods 0.000 claims description 5
- 229940125904 compound 1 Drugs 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 3
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 claims description 3
- 238000005935 nucleophilic addition reaction Methods 0.000 claims description 3
- 125000002587 enol group Chemical group 0.000 claims 1
- 150000002085 enols Chemical class 0.000 abstract description 5
- 230000003287 optical effect Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 239000000543 intermediate Substances 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 238000007259 addition reaction Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- 238000003756 stirring Methods 0.000 description 39
- 239000012074 organic phase Substances 0.000 description 22
- 238000001035 drying Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 238000001914 filtration Methods 0.000 description 18
- 238000010792 warming Methods 0.000 description 18
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
- 239000012044 organic layer Substances 0.000 description 15
- 239000000047 product Substances 0.000 description 12
- 239000000376 reactant Substances 0.000 description 12
- 238000013517 stratification Methods 0.000 description 12
- 235000002639 sodium chloride Nutrition 0.000 description 11
- 239000008346 aqueous phase Substances 0.000 description 9
- 239000012043 crude product Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 230000006837 decompression Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229940056729 sodium sulfate anhydrous Drugs 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 4
- 238000012805 post-processing Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- PTBJMZRCNVWZGU-LGVFNWMJSA-N C[C@@]([C@@H]([C@@H](COC(c1ccccc1)=O)O1)[O](C(c2ccccc2)=O)#C)(C1=C)C#C Chemical compound C[C@@]([C@@H]([C@@H](COC(c1ccccc1)=O)O1)[O](C(c2ccccc2)=O)#C)(C1=C)C#C PTBJMZRCNVWZGU-LGVFNWMJSA-N 0.000 description 1
- JDBKMOVVMNIVIG-RRTUNXMHSA-N C[O](C(CCC[C@@H]1[F]#C)O)C(C2)(C2OC(c2ccccc2)=O)[C@H]1[O](C(c1ccccc1)=O)#C Chemical compound C[O](C(CCC[C@@H]1[F]#C)O)C(C2)(C2OC(c2ccccc2)=O)[C@H]1[O](C(c1ccccc1)=O)#C JDBKMOVVMNIVIG-RRTUNXMHSA-N 0.000 description 1
- YSGPYVWACGYQDJ-UHFFFAOYSA-N D-glyceraldehyde acetonide Natural products CC1(C)OCC(C=O)O1 YSGPYVWACGYQDJ-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The invention provides a preparation method of fluorodesoxyribofuranose. The structure of the fluorodesoxyribofuranose is represented by general formula 1 shown in the description; and the general formula 1, 1a:R = F, and R' = Me; and 1b:R = Me, and R' = F. The fluorodesoxyribofuranose prepared through the brand new preparation method can be used in researching of new medicines, or can be used in researches as a research model. The method adopts glyceraldehyde acetonide as a raw material and allows enantiomers in all intermediates to be effectively separated through a four-step reaction by adopting a rectification or distillation and re-crystallization technology, and a 2-posiion single optical isomer in the target product is directly constructed through an enol addition reaction, so the preparation of the target compound is smooth completed, and the method has the advantages of high yield, simple operation, and suitableness for promotion and application.
Description
Technical field
The present invention relates to the field of chemical synthesis, be specifically related to a kind of preparation method, particularly relate to a kind of preparation method of fluorodeoxy ribofuranose.
Background technology
D-2-ribodesose is a derivative that 2 hydroxyls are replaced by hydrogen of ribose.It as the component of thymus nucleic acid DNA, has a very important role in cell.In DNA, due to r-ray or containing the antibiotic stimulation of alkene-acetylene bond, cause the damage of oxidisability DNA sometimes, namely ribodesose damage occurs, thus causes pathology.
Fluorodeoxy ribofuranose, owing to introducing more stable carbon-fluorine bond, is introduced in DNA, ribodesose can be made to damage and be difficult to occur; This result for the damage of further investigation ribodesose and biological action provide more stable research model, meanwhile, also make this compounds be widely used in the research and development of new drug.Fluorodeoxy ribofuranose as shown in summary of the invention Chinese style (1a), as the key component of anti-third liver star medicine Suo Feibuwei, is pharmacologically playing vital role.Therefore, the preparation method researching and developing this compounds has outstanding meaning.
In fact, for compound 1a, in prior art, openly report multiple synthetic method, but there is the shortcomings such as synthetic route is long, yield is low, stereoselectivity is poor in these methods, is not suitable for scale operation usually.Such as:
Early stage method take L-arabinose as raw material, and just can prepare the analogue 11 of compound 1a through 11 step reactions, concrete synthetic route is:
In addition, most method take glyceraldehyde acetonide as raw material, is first obtained by reacting compound 13 by two hydroxyl oxidize, on this basis, different methods has prepared different intermediates, then prepares compound 1a by fluoro-reaction and ring closure reaction, and concrete synthetic route is:
Also a kind of method is the method being widely used in industrialized production compound 1a at present, this method with the triethylamine salt of hydrofluoric acid for fluoro reagent replaces expensive diethylaminosulfurtrifluoride (DAST) and compound reacts for committed step, successfully achieve the scale operation of compound 1a, concrete synthetic route is:
Another kind method obtains compound by the Reformatsky condensation reaction of glyceraldehyde acetonide, compound is prepared through reactions such as peroxidation, fluoro, reduction, but this method route is long, need the oxidation-reduction state adjustment through twice, and the diastereomer 27 generated need be separated and could obtain 27a by purifying by chromatographic column, concrete synthetic route is:
Also have bibliographical information a kind of the short-cut method needing three-step reaction to prepare compound 1a, but, this method stereoselectivity is poor, four diastereomers producing are difficult to separation and purification, wherein, the method that in document, trial enzyme splits carrys out separate targets product 1a, but effect bad, and concrete synthetic route is:
Therefore, at present, a kind of method of easier, efficient synthesizing fluoro desoxyribofu-is those skilled in the art in the urgent need to.
Summary of the invention
Based on above-mentioned background technology, the invention provides a kind of novel method preparing fluorodeoxy ribofuranose, wherein, take glyceraldehyde acetonide as raw material, by four-step reaction, rectifying or distillation is adopted to have effectively achieved being separated of enantiomer in each intermediate with the method for recrystallization, especially, the single optical isomer of 2-position in target product by enol addition reaction direct construction, thus complete the preparation of target compound smoothly.
Theme of the present invention is a kind of preparation method of fluorodeoxy ribofuranose, and wherein, the structure of described fluorodeoxy ribofuranose is as shown in general formula 1:
(1), wherein, 1a:R=F, R'=Me; 1b:R=Me, R'=F; It is characterized in that, its synthetic route is:
Its synthesis step comprises:
(1) glyceraldehyde acetonide and ethyl ester compound carry out condensation reaction and obtain each other 31 of enantiomer and the mixture of 32;
(2) compound 33 is obtained with acid treatment compound 31;
(3) compound 33 carries out the mixture that benzoylation obtains 34 and 35;
(4) described 34 and 35 mixture tertiary butyl dimethyl silyl triflate and triethylamine process, obtain enol form compound 36;
(5) there is trans nucleophilic addition in compound 36 under the effect of nucleophilic reagent, obtains compound 1.
Wherein, the mixture employing rectifying of 31 and 32 or the method for distillation of the described enantiomer each other obtained in step (1) carry out separating-purifying.
In one embodiment of the invention, described ethyl ester class is the bromo-2-ethyl fluoroacetate of 2-or ethyl propionate.Because condensation reaction has higher trans selective, the primary product therefore in step (1) is compound 31; Further preferably, present inventor surprisingly finds, adopts the method for rectifying or distillation, carries out further separating-purifying, can obtain the higher compound of purity 31 to the mixture of 31 and 32 of described enantiomer each other.
In another embodiment of the present invention, compound 31, in alcohol reagent, obtains compound 33 with acid treatment; Further preferably, described alcohol reagent selects ethanol; Hydrochloric acid, sulfuric acid, tosic acid etc. are selected in described acid.The compound 33 obtained in this step is directly used in next step reaction, and without the need to carrying out the operation of isolation andpurification.
In an embodiment of the present invention, compound 33 preferably carries out benzoylation reaction in acetonitrile reagent; Further, the mixture to obtained 34 and 35 carries out recrystallization, not only obtains highly purified product, and thoroughly eliminates simultaneously and derive by cis-product 32 by product got off.Preferably, described crystallization adopts Virahol to carry out.
In one embodiment, described nucleophilic reagent is methyl iodide or 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt.
Further, in step (5), preferably carry out recrystallization to reaction product, thus obtain highly purified the finished product, be i.e. compound 1, wherein, more preferably, described recrystallization adopts Virahol to carry out as solvent.
In a preferred embodiment of the invention, a kind of preparation method of fluorodeoxy ribofuranose, the structural formula of described fluorodeoxy ribofuranose is as shown in general formula 1a:
(1a); It is characterized in that, its synthesis step is:
(1) in containing the tetrahydrofuran solution of zinc powder, drip bromo-2 ethyl fluoroacetates of 2-and glyceraldehyde acetonide, be obtained by reacting compound 31a;
(2) compound 31a, ethanol and concentrated hydrochloric acid hybrid reaction, obtain compound 33a;
(3) compound 33a, acetonitrile, DMAP and Benzoyl chloride hybrid reaction, obtain the mixture of 34a and 35a;
(4) in the dichloromethane solution of mixture being dissolved with 34a and 35a, drip triethylamine and tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36a;
(5) in the DMF solution being dissolved with compound 36a, add methyl iodide, be obtained by reacting compound 1a.
In a preferred embodiment of the invention, a kind of preparation method of fluorodeoxy ribofuranose, the structural formula of described fluorodeoxy ribofuranose is as shown in general formula 1b:
(1b); It is characterized in that, its synthesis step is:
(1) in the tetrahydrofuran solution of Diisopropylamine, drip n-Butyl Lithium form lithium diisopropylamine, then drip ethyl propionate and glyceraldehyde acetonide, be obtained by reacting compound 31b;
(2) compound 31b, ethanol and concentrated hydrochloric acid hybrid reaction, obtain compound 33b;
(3) compound 33b, acetonitrile, DMAP and Benzoyl chloride hybrid reaction, obtain the mixture of 34b and 35b;
(4) in the dichloromethane solution of mixture being dissolved with 34b and 35b, drip triethylamine and tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36b;
(5) in the DMF solution being dissolved with compound 36b, add 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, be obtained by reacting compound 1b.
In one particular embodiment of the present invention, the preparation method of described 1a is:
(1) under nitrogen protection, zinc powder and anhydrous tetrahydro furan are put in reaction flask, then slowly drip the bromo-2 ethyl fluoroacetate solution of 2-being dissolved in tetrahydrofuran (THF), more slowly drip (the R)-glyceraldehyde acetonide solution being dissolved in tetrahydrofuran (THF), be obtained by reacting compound 31a;
(2) gained compound 31a, ethanol and concentrated hydrochloric acid are put in reaction flask, be obtained by reacting compound 33a, be directly used in next step reaction;
(3) under nitrogen protection, compound 33a, acetonitrile, DMAP and Benzoyl chloride are put in reaction flask, drip triethylamine, after reaction terminates, obtain compound 34a/35a with recrystallisation from isopropanol;
(4) compound 34a/35a and methylene dichloride are dropped in reaction flask, slowly drip triethylamine, then drip tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36a;
(5) compound 36a is dissolved in DMF, adds methyl iodide, after reaction terminates, obtain compound 1a with recrystallisation from isopropanol.
In one particular embodiment of the present invention, the preparation method of described 1b is:
(1) under nitrogen protection, tetrahydrofuran (THF), Diisopropylamine are put in reaction flask, slowly drip 2.5M n-Butyl Lithium, then the toluene solution of ethyl propionate and R-glyceraldehyde acetonide is dripped, after reaction terminates, rectifying or distillation, collect 90-110 DEG C of cut and obtain compound 31b;
(2) compound 31b, ethanol and concentrated hydrochloric acid are put in reaction flask, be obtained by reacting compound 33b;
(3) under nitrogen protection, compound 33b, acetonitrile, DMAP and Benzoyl chloride are put in reaction flask, drip triethylamine, after reaction terminates, obtain compound 34b/35b with recrystallisation from isopropanol;
(4) under nitrogen protection, compound 34b/35b and methylene dichloride are dropped in reaction flask, slowly drips triethylamine, then add tertiary butyl dimethyl silyl triflate, obtain compound 36b;
(5) compound 36b is dissolved in DMF, adds 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, after reaction terminates, obtain compound 1b with recrystallisation from isopropanol.
In preparation method, except necessary post-processing step described above, the present invention does not get rid of other auxiliary post-processing step, and wherein, in a preferred specific embodiment of the present invention, the preparation method of described 1a is:
(1) under nitrogen protection, zinc powder is put in advance in dry anhydrous reaction flask, anhydrous tetrahydro furan is added with syringe, slow dropping is dissolved in the 2-bromo-2-ethyl fluoroacetate solution of tetrahydrofuran (THF), after adding, stirring at room temperature reaction 30min, slowly drips (the R)-glyceraldehyde acetonide solution being dissolved in tetrahydrofuran (THF), after adding, stirring at room temperature reaction 1h; Water and isopropyl ether are joined in reaction system, leave standstill separatory, aqueous phase isopropyl ether extracting twice, merge organic phase, with dilute hydrochloric acid and water washing once, then use anhydrous sodium sulfate drying, filter, be evaporated to dry, obtain compound 31a;
(2) put in reaction flask by gained compound 31a, ethanol and concentrated hydrochloric acid, room temperature reaction spends the night, and is evaporated to toluene evaporate to dryness under 60 DEG C of conditions, gained compound 33a, can be directly used in next step reaction;
(3) under nitrogen protection, put in reaction flask by the crude product of compound 33a, acetonitrile, DMAP and Benzoyl chloride, ice bath is cooled to 0 DEG C-5 DEG C, starts to drip triethylamine, after dripping off, is naturally warming up to room temperature reaction 30min; Add ethyl acetate, water stirs 30min, stratification, collected organic layer, use saturated sodium bicarbonate solution, saturated common salt water washing organic phase successively, layering, organic layer is dry with Sodium sulfate anhydrous.min(99), after filtration, under 60 DEG C of conditions, concentrating under reduced pressure is done, and adds Virahol, be warming up to 80 DEG C, stir 10min, be cooled to 0 DEG C-10 DEG C, crystallization 1h, filters, filter cake washed with isopropyl alcohol cold on a small quantity, 50 DEG C of decompression dryings, obtain compound 34a/35a;
(4) under nitrogen protection, compound 34a/35a and methylene dichloride are dropped in reaction flask, stirring and dissolving, is cooled to 0 DEG C, slowly drips triethylamine, then drips tertiary butyl dimethyl silyl triflate, drips, stirring reaction 30min at 0 DEG C; In reactant, add shrend to go out reaction, stratification, aqueous phase uses dichloromethane extraction three times again, merges organic phase, with anhydrous sodium sulfate drying, after filtration, is evaporated to dry, obtains compound 36a;
(5) compound 36a is dissolved in DMF, in cooling-40 DEG C, adds methyl iodide, after adding, rise to room temperature, stirring reaction 1h; In reactant, add shrend to go out reaction, be extracted with ethyl acetate three times, merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, gained crude product recrystallisation from isopropanol, obtains compound as white solid 1a.
In another one specific embodiment of the present invention, the preparation method of described 1b is:
(1) under nitrogen protection, tetrahydrofuran (THF), Diisopropylamine are put in reaction flask, liquid nitrogen cooling is to-78 DEG C, slow dropping 2.5M n-Butyl Lithium, drips off and is slowly warming up to-10 DEG C afterwards, stirs 30min, again with liquid nitrogen cooling extremely-78 DEG C, drip the toluene solution of ethyl propionate and R-glyceraldehyde acetonide, drip off rear insulation reaction 30min, be naturally warming up to room temperature reaction 2h; Control temperature less than 20 DEG C, with 28% potassium dihydrogen phosphate cancellation reaction, add ethyl acetate and extract 3 times, layering, merge organic layer concentrated dry, underpressure distillation, collects 90 DEG C of-110 DEG C of fractions, obtains compound 31b;
(2) put in reaction flask by compound 31b, ethanol and concentrated hydrochloric acid, room temperature reaction spends the night, 60 DEG C of concentrating under reduced pressure, and toluene evaporate to dryness, obtains compound 33b;
(3) under nitrogen protection, put in reaction flask by compound 33b, acetonitrile, DMAP and Benzoyl chloride, ice bath is cooled to 0 DEG C-5 DEG C, starts to drip triethylamine, after dripping off, is naturally warming up to room temperature reaction 30min; Add ethyl acetate, water stirs 30min, stratification, collected organic layer, use saturated sodium bicarbonate solution, saturated common salt water washing organic phase successively, layering, organic layer is dry with Sodium sulfate anhydrous.min(99), after filtration, 60 DEG C of concentrating under reduced pressure are done, and add Virahol, be warming up to 80 DEG C, stir 10min, be cooled to 0 DEG C-10 DEG C, crystallization 1h, filters, filter cake washed with isopropyl alcohol cold on a small quantity, 50 DEG C of decompression dryings, obtain compound 34b/35b;
(4) under nitrogen protection, compound 34b/35b and methylene dichloride are dropped in reaction flask, stirring and dissolving, is cooled to 0 DEG C, slowly drips triethylamine, then adds tertiary butyl dimethyl silyl triflate, after adding, and stirring reaction 30min at 0 DEG C; In reactant, add shrend to go out reaction, stratification, aqueous phase uses dichloromethane extraction three times again, merges organic phase, with anhydrous sodium sulfate drying, after filtration, is evaporated to dry, obtains compound 36b;
(5) compound 36b is dissolved in DMF, is cooled to-40 DEG C, add 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, after adding, rise to room temperature, stirring reaction 1h, in reactant, add shrend to go out reaction, be extracted with ethyl acetate three times, merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, gained crude product recrystallisation from isopropanol, obtains compound as white solid 1b.
Further, embody particularly in a particular embodiment of the present invention in technical solution of the present invention, certainly, theme of the present invention is a kind of preparation method of compound, mainly lays particular emphasis on the innovation of method, therefore, the general introduction of synthetic route and synthesis step is technical characteristics of the present invention, in addition, present inventor is also unexpected has found the post-treating method being especially adapted to each synthesis step of the present invention, can obtain highly purified corresponding reaction product.On this basis, those skilled in the art can be optimized it according to routine techniques means, but its net result is still encompassed in theme of the present invention, the above-mentioned embodiment about concrete preparation method or preferred embodiment, only for making technician understand theme of the present invention further, and be not limit the present invention.
Relative to prior art, the present invention is by a kind of brand-new preparation method, prepare a kind of fluorodeoxy ribofuranose, may be used for new drug research and development and as research model for studying use, wherein said method take glyceraldehyde acetonide as raw material, pass through four-step reaction, rectifying or distillation is adopted to have effectively achieved being separated of enantiomer in each intermediate with the method for recrystallization, especially, the single optical isomer of 2-position in target product by enol addition reaction direct construction, thus complete the preparation of target compound smoothly, yield is high, easy and simple to handle, be suitable for promotion and application.
Embodiment
Theme of the present invention is a kind of preparation method of fluorodeoxy ribofuranose, and wherein, the structure of described fluorodeoxy ribofuranose is as shown in general formula 1:
(1), wherein, 1a:R=F, R'=Me; 1b:R=Me, R'=F; It is characterized in that, its synthetic route is:
Its synthesis step comprises:
(1) glyceraldehyde acetonide and ethyl ester compound carry out condensation reaction and obtain each other 31 of enantiomer and the mixture of 32;
(2) compound 33 is obtained with acid treatment compound 31;
(3) compound 33 carries out the mixture that benzoylation obtains 34 and 35;
(4) described 34 and 35 mixture tertiary butyl dimethyl silyl triflate and triethylamine process, obtain enol form compound 36;
(5) there is trans nucleophilic addition in compound 36 under the effect of nucleophilic reagent, obtains compound 1;
Wherein, the mixture employing rectifying of 31 and 32 or the method for distillation of the described enantiomer each other obtained in step (1) carry out separating-purifying.
In one embodiment of the invention, described ethyl ester class is the bromo-2-ethyl fluoroacetate of 2-or ethyl propionate.Because condensation reaction has higher trans selective, the primary product therefore in step (1) is compound 31; Further preferably, present inventor surprisingly finds, adopts the method for rectifying or distillation, carries out further separating-purifying, can obtain the higher compound of purity 31 to the mixture of 31 and 32 of described enantiomer each other.
In another embodiment of the present invention, compound 31, in alcohol reagent, obtains compound 33 with acid treatment; Further preferably, described alcohol reagent selects ethanol; Hydrochloric acid, sulfuric acid, tosic acid etc. are selected in described acid.The compound 33 obtained in this step is directly used in next step reaction, and without the need to carrying out the operation of isolation andpurification.
In an embodiment of the present invention, compound 33 preferably carries out benzoylation reaction in acetonitrile reagent; Further, the mixture to obtained 34 and 35 carries out recrystallization, not only obtains highly purified product, and thoroughly eliminates simultaneously and derive by cis-product 32 by product got off.Preferably, described crystallization adopts Virahol to carry out.
In one embodiment, described nucleophilic reagent is methyl iodide or 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt.
Further, in step (5), preferably carry out recrystallization to reaction product, thus obtain highly purified the finished product, be i.e. compound 1, wherein, more preferably, described recrystallization adopts Virahol to carry out as solvent.
In a preferred embodiment of the invention, a kind of preparation method of fluorodeoxy ribofuranose, the structural formula of described fluorodeoxy ribofuranose is as shown in general formula 1a:
(1a); It is characterized in that, its synthesis step is:
(1) in containing the tetrahydrofuran solution of zinc powder, drip bromo-2 ethyl fluoroacetates of 2-and glyceraldehyde acetonide, be obtained by reacting compound 31a;
(2) compound 31a, ethanol and concentrated hydrochloric acid hybrid reaction, obtain compound 33a;
(3) compound 33a, acetonitrile, DMAP and Benzoyl chloride hybrid reaction, obtain the mixture of 34a and 35a;
(4) in the dichloromethane solution of mixture being dissolved with 34a and 35a, drip triethylamine and tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36a;
(5) in the DMF solution being dissolved with compound 36a, add methyl iodide, be obtained by reacting compound 1a.
In a preferred embodiment of the invention, a kind of preparation method of fluorodeoxy ribofuranose, the structural formula of described fluorodeoxy ribofuranose is as shown in general formula 1b:
(1b); It 20 is characterised in that, its synthesis step is:
(1) in the tetrahydrofuran solution of Diisopropylamine, drip n-Butyl Lithium form lithium diisopropylamine, then drip ethyl propionate and glyceraldehyde acetonide, be obtained by reacting compound 31b;
(2) compound 31b, ethanol and concentrated hydrochloric acid hybrid reaction, obtain compound 33b;
(3) compound 33b, acetonitrile, DMAP and Benzoyl chloride hybrid reaction, obtain the mixture of 34b and 35b;
(4) in the dichloromethane solution of mixture being dissolved with 34b and 35b, drip triethylamine and tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36b;
(5) in the DMF solution being dissolved with compound 36b, add 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, be obtained by reacting compound 1b.
In one particular embodiment of the present invention, the preparation method of described 1a is:
(1) under nitrogen protection, zinc powder and anhydrous tetrahydro furan are put in reaction flask, then slowly drip the bromo-2 ethyl fluoroacetate solution of 2-being dissolved in tetrahydrofuran (THF), more slowly drip (the R)-glyceraldehyde acetonide solution being dissolved in tetrahydrofuran (THF), be obtained by reacting compound 31a;
(2) gained compound 31a, ethanol and concentrated hydrochloric acid are put in reaction flask, be obtained by reacting compound 33a, be directly used in next step reaction;
(3) under nitrogen protection, compound 33a, acetonitrile, DMAP and Benzoyl chloride are put in reaction flask, drip triethylamine, after reaction terminates, obtain compound 34a/35a with recrystallisation from isopropanol;
(4) compound 34a/35a and methylene dichloride are dropped in reaction flask, slowly drip triethylamine, then drip tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36a;
(5) compound 36a is dissolved in DMF, adds methyl iodide, after reaction terminates, obtain compound 1a with recrystallisation from isopropanol.
In one particular embodiment of the present invention, the preparation method of described 1b is:
(1) under nitrogen protection, tetrahydrofuran (THF), Diisopropylamine are put in reaction flask, slowly drip 2.5M n-Butyl Lithium, then the toluene solution of ethyl propionate and R-glyceraldehyde acetonide is dripped, after reaction terminates, rectifying or distillation, collect 90-110 DEG C of cut and obtain compound 31b;
(2) compound 31b, ethanol and concentrated hydrochloric acid are put in reaction flask, be obtained by reacting compound 33b;
(3) under nitrogen protection, compound 33b, acetonitrile, DMAP and Benzoyl chloride are put in reaction flask, drip triethylamine, after reaction terminates, obtain compound 34b/35b with recrystallisation from isopropanol;
(4) under nitrogen protection, compound 34b/35b and methylene dichloride are dropped in reaction flask, slowly drips triethylamine, then add tertiary butyl dimethyl silyl triflate, obtain compound 36b;
(5) compound 36b is dissolved in DMF, adds 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, after reaction terminates, obtain compound 1b with recrystallisation from isopropanol.
In preparation method, except necessary post-processing step described above, the present invention does not get rid of other auxiliary post-processing step, and wherein, in a preferred specific embodiment of the present invention, the preparation method of described 1a is:
(1) under nitrogen protection, zinc powder is put in advance in dry anhydrous reaction flask, anhydrous tetrahydro furan is added with syringe, slow dropping is dissolved in the bromo-2 ethyl fluoroacetate solution of 2-of tetrahydrofuran (THF), after adding, stirring at room temperature reaction 30min, slowly drips (the R)-glyceraldehyde acetonide solution being dissolved in tetrahydrofuran (THF), after adding, stirring at room temperature reaction 1h; Water and isopropyl ether are joined in reaction system, leave standstill separatory, aqueous phase isopropyl ether extracting twice, merge organic phase, with dilute hydrochloric acid and water washing once, then use anhydrous sodium sulfate drying, filter, be evaporated to dry, obtain compound 31a;
(2) put in reaction flask by gained compound 31a, ethanol and concentrated hydrochloric acid, room temperature reaction spends the night, and is evaporated to toluene evaporate to dryness under 60 DEG C of conditions, gained compound 33a, can be directly used in next step reaction;
(3) under nitrogen protection, put in reaction flask by the crude product of compound 33a, acetonitrile, DMAP and Benzoyl chloride, ice bath is cooled to 0 DEG C-5 DEG C, starts to drip triethylamine, after dripping off, is naturally warming up to room temperature reaction 30min; Add ethyl acetate, water stirs 30min, stratification, collected organic layer, use saturated sodium bicarbonate solution, saturated common salt water washing organic phase successively, layering, organic layer is dry with Sodium sulfate anhydrous.min(99), after filtration, under 60 DEG C of conditions, concentrating under reduced pressure is done, and adds Virahol, be warming up to 80 DEG C, stir 10min, be cooled to 0 DEG C-10 DEG C, crystallization 1h, filters, filter cake washed with isopropyl alcohol cold on a small quantity, 50 DEG C of decompression dryings, obtain compound 34a/35a;
(4) under nitrogen protection, compound 34a/35a and methylene dichloride are dropped in reaction flask, stirring and dissolving, is cooled to 0 DEG C, slowly drips triethylamine, then drips tertiary butyl dimethyl silyl triflate, drips, stirring reaction 30min at 0 DEG C; In reactant, add shrend to go out reaction, stratification, aqueous phase uses dichloromethane extraction three times again, merges organic phase, with anhydrous sodium sulfate drying, after filtration, is evaporated to dry, obtains compound 36a;
(5) compound 36a is dissolved in DMF, in cooling-40 DEG C, adds methyl iodide, after adding, rise to room temperature, stirring reaction 1h; In reactant, add shrend to go out reaction, be extracted with ethyl acetate three times, merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, gained crude product recrystallisation from isopropanol, obtains compound as white solid 1a.
In another one specific embodiment of the present invention, the preparation method of described 1b is:
(1) under nitrogen protection, tetrahydrofuran (THF), Diisopropylamine are put in reaction flask, liquid nitrogen cooling is to-78 DEG C, slow dropping 2.5M n-Butyl Lithium, drips off and is slowly warming up to-10 DEG C afterwards, stirs 30min, again with liquid nitrogen cooling extremely-78 DEG C, drip the toluene solution of ethyl propionate and R-glyceraldehyde acetonide, drip off rear insulation reaction 30min, be naturally warming up to room temperature reaction 2h; Control temperature less than 20 DEG C, with 28% potassium dihydrogen phosphate cancellation reaction, add ethyl acetate and extract 3 times, layering, merge organic layer concentrated dry, underpressure distillation, collects 90 DEG C of-110 DEG C of fractions, obtains compound 31b;
(2) put in reaction flask by compound 31b, ethanol and concentrated hydrochloric acid, room temperature reaction spends the night, 60 DEG C of concentrating under reduced pressure, and toluene evaporate to dryness, obtains compound 33b;
(3) under nitrogen protection, put in reaction flask by compound 33b, acetonitrile, DMAP and Benzoyl chloride, ice bath is cooled to 0 DEG C-5 DEG C, starts to drip triethylamine, after dripping off, is naturally warming up to room temperature reaction 30min; Add ethyl acetate, water stirs 30min, stratification, collected organic layer, use saturated sodium bicarbonate solution, saturated common salt water washing organic phase successively, layering, organic layer is dry with Sodium sulfate anhydrous.min(99), after filtration, 60 DEG C of concentrating under reduced pressure are done, and add Virahol, be warming up to 80 DEG C, stir 10min, be cooled to 0 DEG C-10 DEG C, crystallization 1h, filters, filter cake washed with isopropyl alcohol cold on a small quantity, 50 DEG C of decompression dryings, obtain compound 34b/35b;
(4) under nitrogen protection, compound 34b/35b and methylene dichloride are dropped in reaction flask, stirring and dissolving, is cooled to 0 DEG C, slowly drips triethylamine, then adds tertiary butyl dimethyl silyl triflate, after adding, and stirring reaction 30min at 0 DEG C; In reactant, add shrend to go out reaction, stratification, aqueous phase uses dichloromethane extraction three times again, merges organic phase, with anhydrous sodium sulfate drying, after filtration, is evaporated to dry, obtains compound 36b;
(5) compound 36b is dissolved in DMF, is cooled to-40 DEG C, add 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, after adding, rise to room temperature, stirring reaction 1h, in reactant, add shrend to go out reaction, be extracted with ethyl acetate three times, merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, gained crude product recrystallisation from isopropanol, obtains compound as white solid 1b.
According to technique scheme provided by the invention, existing by following examples content of the present invention explained further and illustrate.
Embodiment 1---the synthesis of compound 31b
Under nitrogen protection, by tetrahydrofuran (THF) (500mL), Diisopropylamine (66.1g, 0.65mol) put in reaction flask, liquid nitrogen cooling is to-78 DEG C, slow dropping 2.5M n-Butyl Lithium (261mL, 0.65mol), drip off and be slowly warming up to-10 DEG C afterwards, stir 30min, again with liquid nitrogen cooling extremely-78 DEG C, drip ethyl propionate (58.8g, 0.58mol) with R-glyceraldehyde acetonide (50.0g, toluene (250mL) solution 0.49mol), drip off rear insulation reaction 30min, naturally room temperature reaction 2h is warming up to, control temperature less than 20 DEG C, react with 28% potassium dihydrogen phosphate (600mL) cancellation, add ethyl acetate (200mL) and extract 3 times, layering, merge organic layer concentrated dry, decompression (50pa-100pa) distillation, collect 90 DEG C of-110 DEG C of fractions, obtain 31b (54.2g, yield 60.8%, configuration ratio is 31b/32b=89.4:10.6).
Embodiment 2---the synthesis of compound 33b
Put in reaction flask by compound 31b (15g, 0.065mol), ethanol (75mL) and concentrated hydrochloric acid (5mL), room temperature reaction spends the night, 60 DEG C of concentrating under reduced pressure.Toluene band evaporate to dryness, obtains 33b (8.7g, yield 92.2%).
Embodiment 3---the synthesis of compound 34b/35b
Under nitrogen protection, by compound 33b (7.4g, 50.6mmol), acetonitrile (50mL), DMAP (0.3g, 2.5mmol) with Benzoyl chloride (17.8g, 126.6mmol) put in reaction flask, ice bath is cooled to 0 DEG C-5 DEG C, start to drip triethylamine (12.8g, 0.1266mol), after dripping off, naturally room temperature reaction 30min is warming up to, add ethyl acetate (50mL), water (50g) stirs 30min, stratification, collected organic layer, use saturated sodium bicarbonate solution (20mL) successively, saturated aqueous common salt (20mL) washs organic phase, layering, organic layer is dry with Sodium sulfate anhydrous.min(99), after filtration, 60 DEG C of concentrating under reduced pressure are done, add Virahol (70mL), be warming up to 80 DEG C, stir 10min, be cooled to 0 DEG C-10 DEG C, crystallization 1h, filter, filter cake washed with isopropyl alcohol cold on a small quantity, 50 DEG C of decompression dryings, obtain compound 34b/35b (8.1g, yield 54.4%).1HNMR(400MHz,CDCl3)δ8.08–7.97(m,4H),7.60(dt,J=21.2,7.4Hz,2H),7.45(dt,J=20.7,7.8Hz,4H),5.42–5.35(m,1H),4.81(dd,J=8.5,5.0Hz,1H),4.69(qd,J=12.3,4.1Hz,2H),3.02(dt,J=14.8,7.4Hz,1H),1.50(d,J=7.5Hz,3H)。
Embodiment 4---the synthesis of compound 1b
Under nitrogen protection, the mixture (3.54g, 10mmol) of 34b/35b and methylene dichloride (100mL) are dropped in reaction flask, stirring and dissolving.Be cooled to 0 DEG C, slowly drip triethylamine (4.7mL, 35mmol), then add tertiary butyl dimethyl silyl triflate (4.23g, 16mmol).Add, stirring reaction 30min at 0 DEG C, in reactant, add 120mL shrend to go out reaction, stratification, aqueous phase uses dichloromethane extraction three times again, merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, products therefrom is dissolved in N, in dinethylformamide (100mL), in cooling-40 DEG C, add 1-chloromethyl-4-fluoro-1, 4-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt (7.08g, 20mmol), after adding, rise to room temperature, stirring reaction 1h, in reactant, add 300mL shrend to go out reaction, be extracted with ethyl acetate three times (3x200mL), merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, gained crude product recrystallisation from isopropanol, obtain compound as white solid 1b (2.1g, 56.4%).Optical value: [α]=+ 24.9 (c1.0, CH2Cl2) .1HNMR (400MHz, CDCl3): δ 8.03 (d, J=7.6Hz, 4H), 7.63 (d, J=7.6Hz, 1H), 7.56 (d, J=7.6Hz, 1H), 7.51-7.40 (m, 4H), 5.84 (dd, J=18.8Hz, 5.2Hz, 1H), 4.76-4.74 (m, 2H), 4.60 (d, J=5.4Hz, 1H), 1.78 (d, J=23.2Hz, 3H).
Embodiment 5---the synthesis of compound 33a
Under nitrogen protection, by zinc powder (24.2g, 0.37mol) input in advance dry anhydrous reaction flask.Anhydrous tetrahydro furan (300mL) is added with syringe, slow dropping is dissolved in the bromo-2 ethyl fluoroacetate (46.9g of 2-of 80mL tetrahydrofuran (THF), 0.25mol) solution, after adding, stirring at room temperature reaction 30min, slow dropping is dissolved in (R)-glyceraldehyde acetonide (33g of 80mL tetrahydrofuran (THF), 0.253mol) solution, after adding, stirring at room temperature reaction 1h, water and isopropyl ether are joined in reaction system, leaves standstill separatory.Aqueous phase isopropyl ether extracting twice, merge organic phase, with dilute hydrochloric acid and water washing once, organic phase anhydrous sodium sulfate drying, filters, be evaporated to dry, put in reaction flask by gained compound 31a, ethanol (165mL) and concentrated hydrochloric acid (10mL), room temperature reaction spends the night, 60 DEG C of concentrating under reduced pressure, toluene band evaporate to dryness, products therefrom is directly used in next step reaction.
Embodiment 6---the synthesis of compound 34a/35a
Under nitrogen protection, by previous step gained crude product (7.4g, 50.6mmol), acetonitrile (140mL), DMAP (0.83g, 7.0mmol) with Benzoyl chloride (49.3g, 350mmol) put in reaction flask, ice bath is cooled to 0 DEG C-5 DEG C, start to drip triethylamine (35.5g, 350mmol), after dripping off, naturally room temperature reaction 30min is warming up to, add ethyl acetate (150mL), water (150g) stirs 30min, stratification, collected organic layer, use saturated sodium bicarbonate solution (60mL) successively, saturated aqueous common salt (60mL) washs organic phase, layering, organic layer is dry with Sodium sulfate anhydrous.min(99), after filtration, 60 DEG C of concentrating under reduced pressure are done, add Virahol (200mL), be warming up to 80 DEG C, stir 10min, be cooled to 0 DEG C-10 DEG C, crystallization 1h, filter, filter cake washed with isopropyl alcohol cold on a small quantity, 50 DEG C of decompression dryings, obtain compound 34a/35a (20.8g, three step total recoverys 23.3%).1HNMR(400MHz,CDCl3)δ8.13–8.01(m,3H),7.99–7.94(m,1H),7.64–7.57(m,1H),7.56–7.50(m,1H),7.49–7.40(m,4H),5.70(d,J=8.1Hz,1H,minor),5.65(d,J=8.1Hz,1H,minor),5.55(d,J=18.8Hz,1H,major),5.47–5.38(m,1H,major,1H,minor),4.81–4.76(m,1H,minor),4.71–4.62(m,1H,major),4.62–4.49(m,1H,major,1H,minor),1.68(d,J=22.0,3H,major),1.66(d,J=22.0,3H,minor)。
Embodiment 7---the synthesis of compound 1a
Under nitrogen protection, the mixture (7.16g, 20mmol) of 34a/35a and methylene dichloride (200mL) are dropped in reaction flask, stirring and dissolving.Be cooled to 0 DEG C, slowly drip triethylamine (9.4mL, 70mmol), drip tertiary butyl dimethyl silyl triflate (8.46g, 32mmol) again, drip, stirring reaction 30min at 0 DEG C, adds 200mL shrend and to go out reaction, stratification in reactant, aqueous phase uses dichloromethane extraction three times again, merges organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, products therefrom is dissolved in DMF (200mL).In cooling-40 DEG C, add methyl iodide (5.68g, 40mmol).After adding, rise to room temperature, stirring reaction 1h, in reactant, add 300mL shrend to go out reaction, be extracted with ethyl acetate three times (3x300mL), merge organic phase, with anhydrous sodium sulfate drying, after filtration, be evaporated to dry, gained crude product recrystallisation from isopropanol, obtains compound as white solid 1a (3.5g, 47%).Fusing point: 135-137 DEG C; Optical value: [α]=+ 24.9 (c1.0, CH2Cl2) .1HNMR (400MHz, DMSO) δ 8.03 (d, J=7.2Hz, 2H), 7.95 (d, J=7.1Hz, 2H), 7.73 (t, J=7.4Hz, 1H), 7.66 (t, J=7.4Hz, 1H), 7.57 (t, J=7.8Hz, 2H), 7.49 (t, J=7.8Hz, 2H), 5.77 (dd, J=18.5,7.1Hz, 1H), 5.15 (td, J=6.7,3.7Hz, 1H), 4.70 (ddd, J=18.9,12.4,5.1Hz, 2H), 1.70 (d, J=24.4Hz, 3H).
Be described in detail specific embodiments of the invention above, but it is just as example, the present invention is not restricted to specific embodiment described above.To those skilled in the art, any equivalent modifications that the present invention is carried out and substituting also all among category of the present invention.Therefore, equalization conversion done without departing from the spirit and scope of the invention and amendment, all should contain within the scope of the invention.
Claims (9)
1. a preparation method for fluorodeoxy ribofuranose, wherein, the structure of described fluorodeoxy ribofuranose is as shown in general formula 1:
wherein, 1a:R=F, R'=Me; 1b:R=Me, R'=F; It is characterized in that, its synthetic route is:
its synthesis step comprises:
(1) glyceraldehyde acetonide and ethyl ester compound carry out condensation reaction and obtain each other 31 of enantiomer and the mixture of 32;
(2) compound 33 is obtained with acid treatment compound 31;
(3) compound 33 carries out the mixture that benzoylation obtains 34 and 35;
(4) described 34 and 35 mixture tertiary butyl dimethyl silyl triflate and triethylamine process, obtain enol form compound 36;
(5) there is trans nucleophilic addition in compound 36 under the effect of nucleophilic reagent, obtains compound 1;
Wherein, the mixture employing rectifying of 31 and 32 or the method for distillation of the described enantiomer each other obtained in step (1) carry out separating-purifying.
2. preparation method according to claim 1, is characterized in that, ethyl ester compound described in step (1) is the bromo-2-ethyl fluoroacetate of 2-or ethyl propionate.
3. preparation method according to claim 1, is characterized in that, the compound 33 obtained in step (2) is directly used in next step reaction, and without the need to carrying out the operation of isolation andpurification.
4. preparation method according to claim 1, is characterized in that, in step (3) and step (5), carries out recrystallization process to reaction product, obtains mixture and the described compound 1 of described 34 and 35 respectively.
5. preparation method according to claim 1, is characterized in that, in step (5), described nucleophilic reagent is methyl iodide or 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt.
6. a preparation method for fluorodeoxy ribofuranose, the structural formula of described fluorodeoxy ribofuranose is as shown in general formula 1a:
it is characterized in that, its synthesis step is:
(1) in containing the tetrahydrofuran solution of zinc powder, drip bromo-2 ethyl fluoroacetates of 2-and glyceraldehyde acetonide, be obtained by reacting compound 31a;
(2) compound 31a, ethanol and concentrated hydrochloric acid hybrid reaction, obtain compound 33a;
(3) compound 33a, acetonitrile, DMAP and Benzoyl chloride hybrid reaction, obtain the mixture of 34a and 35a;
(4) in the dichloromethane solution of mixture being dissolved with 34a and 35a, drip triethylamine and tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36a;
(5) in the DMF solution being dissolved with compound 36a, add methyl iodide, be obtained by reacting compound 1a.
7. preparation method according to claim 6, is characterized in that, described synthesis step is:
(1) under nitrogen protection, zinc powder and anhydrous tetrahydro furan are put in reaction flask, then slowly drip the bromo-2 ethyl fluoroacetate solution of 2-being dissolved in tetrahydrofuran (THF), more slowly drip (the R)-glyceraldehyde acetonide solution being dissolved in tetrahydrofuran (THF), be obtained by reacting compound 31a;
(2) gained compound 31a, ethanol and concentrated hydrochloric acid are put in reaction flask, be obtained by reacting compound 33a, be directly used in next step reaction;
(3) under nitrogen protection, compound 33a, acetonitrile, DMAP and Benzoyl chloride are put in reaction flask, drip triethylamine, after reaction terminates, obtain compound 34a/35a with recrystallisation from isopropanol;
(4) compound 34a/35a and methylene dichloride are dropped in reaction flask, slowly drip triethylamine, then drip tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36a;
(5) compound 36a is dissolved in DMF, adds methyl iodide, after reaction terminates, obtain compound 1a with recrystallisation from isopropanol.
8. a preparation method for fluorodeoxy ribofuranose, the structural formula of described fluorodeoxy ribofuranose is as shown in general formula 1b:
it is characterized in that, its synthesis step is:
(1) in the tetrahydrofuran solution of Diisopropylamine, drip n-Butyl Lithium form lithium diisopropylamine, and then drip ethyl propionate and glyceraldehyde acetonide, be obtained by reacting compound 31b;
(2) compound 31b, ethanol and concentrated hydrochloric acid hybrid reaction, obtain compound 33b;
(3) compound 33b, acetonitrile, DMAP and Benzoyl chloride hybrid reaction, obtain the mixture of 34b and 35b;
(4) in the dichloromethane solution of mixture being dissolved with 34b and 35b, drip triethylamine and tertiary butyl dimethyl silyl triflate, be obtained by reacting compound 36b;
(5) in the DMF solution being dissolved with compound 36b, add 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, be obtained by reacting compound 1b.
9. preparation method according to claim 8, is characterized in that, described synthesis step is:
(1) under nitrogen protection, tetrahydrofuran (THF), Diisopropylamine are put in reaction flask, slowly drip 2.5M n-Butyl Lithium, then the toluene solution of ethyl propionate and R-glyceraldehyde acetonide is dripped, after reaction terminates, rectifying or distillation, collect 90-110 DEG C of cut and obtain compound 31b;
(2) compound 31b, ethanol and concentrated hydrochloric acid are put in reaction flask, be obtained by reacting compound 33b;
(3) under nitrogen protection, compound 33b, acetonitrile, DMAP and Benzoyl chloride are put in reaction flask, drip triethylamine, after reaction terminates, obtain compound 34b/35b with recrystallisation from isopropanol;
(4) under nitrogen protection, compound 34b/35b and methylene dichloride are dropped in reaction flask, slowly drips triethylamine, then add tertiary butyl dimethyl silyl triflate, obtain compound 36b;
(5) compound 36b is dissolved in DMF, adds 1-chloromethyl-4-fluoro-Isosorbide-5-Nitrae-diazabicyclo [2.2.2] octane two (Tetrafluoroboric acid) salt, after reaction terminates, obtain compound 1b with recrystallisation from isopropanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511020367.0A CN105566406A (en) | 2015-12-30 | 2015-12-30 | Preparation method of fluorodesoxyribofuranose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511020367.0A CN105566406A (en) | 2015-12-30 | 2015-12-30 | Preparation method of fluorodesoxyribofuranose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105566406A true CN105566406A (en) | 2016-05-11 |
Family
ID=55877093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201511020367.0A Pending CN105566406A (en) | 2015-12-30 | 2015-12-30 | Preparation method of fluorodesoxyribofuranose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105566406A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102617678A (en) * | 2012-02-22 | 2012-08-01 | 江苏豪森药业股份有限公司 | Method for preparing gemcitabine hydrochloride |
| WO2014124430A1 (en) * | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2015035223A1 (en) * | 2013-09-09 | 2015-03-12 | Peloton Therapeutics, Inc. | Aryl ethers and uses thereof |
-
2015
- 2015-12-30 CN CN201511020367.0A patent/CN105566406A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102617678A (en) * | 2012-02-22 | 2012-08-01 | 江苏豪森药业股份有限公司 | Method for preparing gemcitabine hydrochloride |
| WO2014124430A1 (en) * | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2015035223A1 (en) * | 2013-09-09 | 2015-03-12 | Peloton Therapeutics, Inc. | Aryl ethers and uses thereof |
Non-Patent Citations (2)
| Title |
|---|
| CLAYTON H. HEATHCOCK ET AL.: "Acyclic Stereoselection. 9. Stereochemistry of the Addition of Lithium Enolates to α-Alkoxy Aldehydes", 《J. ORG. CHEM.》 * |
| PINGSHENG ZHANG ET AL.: "A practical synthesis of (2R)-3,5-di-O-benzoyl-2-fluoro-2-C-methyl-D-ribono-γ-lactone", 《TETRAHEDRON:ASYMMETRY》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111205294A (en) | Preparation method of Reidesciclovir intermediate | |
| JP2020523381A (en) | Synthesis of 3'-deoxyadenosine-5'-O-[phenyl(benzyloxy-L-alaninyl)]phosphate (NUC-7738) | |
| CN112574163B (en) | Method for synthesizing Brazilin natural product (+) -Brazilin | |
| CN105585603B (en) | A method of preparing shellfish cholic acid intermediate difficult to understand | |
| CN113214320A (en) | Preparation method of Reidesciclovir compound | |
| JP5717752B2 (en) | Method for producing pyripyropene derivative | |
| CN102348706A (en) | Process for producing pyripyropene derivatives | |
| CN101307048A (en) | Method for preparing lamivadin by stereoselectivity | |
| Sureshan et al. | Sulfonate protecting groups. Regioselective sulfonylation of myo-inositol orthoesters—improved synthesis of precursors of d-and l-myo-inositol 1, 3, 4, 5-tetrakisphosphate, myo-inositol 1, 3, 4, 5, 6-pentakisphosphate and related derivatives | |
| CN112608296B (en) | Synthesis method of Brazilane natural product Brazilane | |
| CN103601782A (en) | Preparation method of prednisone acetate or analogues thereof | |
| JP2018532718A (en) | Phosphoramidate compound, production method thereof and crystal | |
| CN101993447A (en) | Method for synthesizing Prasugrel artificially | |
| JP7146067B2 (en) | Preparation of Intermediates Useful for Synthesis of SGLT Inhibitors | |
| CN114560901B (en) | A preparation method of ergosterol or its derivatives | |
| CN109574961B (en) | Method for preparing sofosbuvir intermediate | |
| Ye et al. | Enantioselective total synthesis of the proposed structure of macrolide iriomoteolide-1b | |
| KR100908363B1 (en) | Stereoselective preparation method of tri-O-acetyl-5-deoxy-β-D-ribofuranose and separation method thereof | |
| CN105566406A (en) | Preparation method of fluorodesoxyribofuranose | |
| CN103641879B (en) | The preparation method of prednisolone intermediate or its analogue | |
| CN103709132A (en) | Method for preparing nebivolol midbody | |
| CN115925702B (en) | A purification method of imidazo[4,5-C]pyridine derivatives and imidazo[4,5-C]pyridine derivatives | |
| CN118598812A (en) | Synthesis method of key intermediate of huperzine A | |
| CN103664837B (en) | A kind of preparation method of high purity Cabazitaxel intermediate | |
| CN117486960A (en) | Preparation method of cholesterol and intermediate thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160511 |